For recognizing all the isolates, Matrix-Assisted Laser Desorption/Ionization-Time of Flight mass spectrometry (MALDI-TOF MS, Vitek MS, bioMérieux, France) was utilized. In accordance with the 2019 Clinical and Laboratory Standards Institute’s recommendations, 28 antibiotics were tested for their susceptibility via VITEK 2 (Card number: AST-GN13) system or Kirby-Bauer Disk Diffusion (Oxoid, UK) (CLSI) method. K. pneumoniae (ATCC700603) and Escherichia coli (ATCC25922) isolates were kept as standards to ensure quality control. Agar dilution assessment with the help of ceftazidime and cefotaxime combined with clavulanate was performed to confirm ESBL. Resistance to carbapenem (meropenem, imipenem, and ertapenem) was confirmed via disk diffusion protocol.